Jacques Buxeraud

564 total citations
92 papers, 423 citations indexed

About

Jacques Buxeraud is a scholar working on Organic Chemistry, General Health Professions and Oncology. According to data from OpenAlex, Jacques Buxeraud has authored 92 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Organic Chemistry, 13 papers in General Health Professions and 11 papers in Oncology. Recurrent topics in Jacques Buxeraud's work include Synthesis and Characterization of Heterocyclic Compounds (10 papers), Health, Medicine and Society (10 papers) and Synthesis and Reactions of Organic Compounds (10 papers). Jacques Buxeraud is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (10 papers), Health, Medicine and Society (10 papers) and Synthesis and Reactions of Organic Compounds (10 papers). Jacques Buxeraud collaborates with scholars based in France, United States and New Zealand. Jacques Buxeraud's co-authors include C Raby, Annick Rousseau, G Catanzano, Pierre Marquet, Christelle Pouget, Catherine Fagnère, Samir Yahiaoui, Sébastien Faure, Gérard Lachâtre and Albert-José Chulia and has published in prestigious journals such as Endocrinology, International Journal of Pharmaceutics and Biochemical Pharmacology.

In The Last Decade

Jacques Buxeraud

64 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacques Buxeraud France 12 137 97 88 58 36 92 423
C Raby France 12 128 0.9× 85 0.9× 86 1.0× 58 1.0× 40 1.1× 50 410
Leszek Siergiejczyk Poland 11 112 0.8× 125 1.3× 20 0.2× 37 0.6× 14 0.4× 36 390
Edward B. Roche United States 13 193 1.4× 164 1.7× 20 0.2× 50 0.9× 20 0.6× 33 542
Nadežda Prónayová Slovakia 11 170 1.2× 69 0.7× 34 0.4× 13 0.2× 46 1.3× 35 352
Ayse Beyaz United States 6 128 0.9× 93 1.0× 113 1.3× 25 0.4× 80 2.2× 6 505
T. NISHIO Japan 15 263 1.9× 314 3.2× 108 1.2× 172 3.0× 17 0.5× 49 753
Sujata K. Dass India 17 217 1.6× 193 2.0× 43 0.5× 21 0.4× 15 0.4× 32 681
Jeffrey Sarver United States 13 66 0.5× 204 2.1× 34 0.4× 47 0.8× 25 0.7× 34 529
Abhay T. Sangamwar India 14 121 0.9× 167 1.7× 11 0.1× 46 0.8× 31 0.9× 28 561
Karl Jacob Germany 15 107 0.8× 241 2.5× 123 1.4× 249 4.3× 28 0.8× 40 896

Countries citing papers authored by Jacques Buxeraud

Since Specialization
Citations

This map shows the geographic impact of Jacques Buxeraud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Buxeraud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Buxeraud more than expected).

Fields of papers citing papers by Jacques Buxeraud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Buxeraud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Buxeraud. The network helps show where Jacques Buxeraud may publish in the future.

Co-authorship network of co-authors of Jacques Buxeraud

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Buxeraud. A scholar is included among the top collaborators of Jacques Buxeraud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Buxeraud. Jacques Buxeraud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buxeraud, Jacques, et al.. (2022). Le nirmatrelvir-ritonavir (Paxlovid®), un traitement contre la Covid-19. Actualités Pharmaceutiques. 61(617). 10–12. 4 indexed citations
2.
Buxeraud, Jacques & Sébastien Faure. (2021). La vitamine C. Actualités Pharmaceutiques. 60(604). S24–S26. 1 indexed citations
3.
Buxeraud, Jacques, et al.. (2019). Pathologies courantes chez la femme enceinte et conseil officinal. Actualités Pharmaceutiques. 58(591). 8–11.
4.
Mœsch, Christian & Jacques Buxeraud. (2017). Les antiseptiques en pratique courante. Actualités Pharmaceutiques. 56(568). 14–20. 1 indexed citations
5.
Buxeraud, Jacques, et al.. (2016). Le résumé des caractéristiques du produit au cours du temps. Actualités Pharmaceutiques. 55(553). 22–23. 1 indexed citations
6.
Yahiaoui, Samir, Christelle Pouget, Jacques Buxeraud, Albert J. Chulia, & Catherine Fagnère. (2011). Lead optimization of 4-imidazolylflavans: New promising aromatase inhibitors. European Journal of Medicinal Chemistry. 46(6). 2541–2545. 13 indexed citations
7.
Mœsch, Christian & Jacques Buxeraud. (2011). Les antiseptiques, des médicaments à part entière. Actualités Pharmaceutiques. 50(505). 16–24.
8.
Yahiaoui, Samir, Catherine Fagnère, Christelle Pouget, Jacques Buxeraud, & Albert-José Chulia. (2007). New 7,8-benzoflavanones as potent aromatase inhibitors: Synthesis and biological evaluation. Bioorganic & Medicinal Chemistry. 16(3). 1474–1480. 27 indexed citations
9.
Buxeraud, Jacques, et al.. (2000). Antithyroid Action of Tamoxifen in the Rat. Pharmacology. 61(1). 22–30. 3 indexed citations
10.
Marquet, Pierre, et al.. (1998). Relationship between Psychotropic Drugs and Thyroid Function: A Review. Toxicology and Applied Pharmacology. 149(2). 127–135. 37 indexed citations
11.
Rousseau, Annick, et al.. (1998). Thyroid Accumulation and Adverse Effects of Imipramine and Desipramine in Rats after Long-Term Administration. Pharmacology. 57(5). 242–248. 8 indexed citations
12.
Rousseau, Annick, et al.. (1997). Anti-Inflammatory Action of Methimazole. Pharmacology. 55(4). 173–178. 12 indexed citations
13.
Rousseau, Annick, et al.. (1997). Sensitive microanalysis of imipramine and desipramine in single rat thyroids by gas chromatography–mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 693(1). 93–100. 4 indexed citations
14.
Buxeraud, Jacques, et al.. (1995). Lymphoproliferative activity of methimazole: Free SH group dependency. General Pharmacology The Vascular System. 26(6). 1363–1367. 1 indexed citations
15.
Rousseau, Annick, et al.. (1993). Synthesis and Antithyroid Activity of Pyridine, Pyrimidine and Pyrazine Derivatives of Thiazole-2-thiol and 2-Thiazoline-2-thiol.. Chemical and Pharmaceutical Bulletin. 41(7). 1258–1260. 13 indexed citations
16.
Buxeraud, Jacques, et al.. (1993). [Antibacterial sulfonamides, antiparasitic and antifungal derivatives of imidazole: evaluation of their antithyroid effects in the rat].. PubMed. 24(4). 316–26. 8 indexed citations
17.
Buxeraud, Jacques, et al.. (1992). Sites of Action of 2-Thiazoline-2-Thiol on Biogenesis of Thyroid Hormones.. The Japanese Journal of Pharmacology. 58(3). 201–207. 15 indexed citations
18.
Buxeraud, Jacques, et al.. (1992). Synthèse et activitè antithyroïdienne de dérivés du triazole. European Journal of Medicinal Chemistry. 27(4). 359–368. 9 indexed citations
19.
Catanzano, G, et al.. (1991). Formation of molecular iodine during oxidation of iodide by the peroxidase/H2O2 system. Biochemical Pharmacology. 42. S89–S92. 14 indexed citations
20.
Buxeraud, Jacques, et al.. (1990). Spectroscopic analysis of charge transfer complexes between morpholine and iodine.. Chemical and Pharmaceutical Bulletin. 38(8). 2172–2174. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C Raby Breakdown of academic impact, for papers by Leszek Siergiejczyk Breakdown of academic impact, for papers by Edward B. Roche Breakdown of academic impact, for papers by Nadežda Prónayová Breakdown of academic impact, for papers by Ayse Beyaz Breakdown of academic impact, for papers by T. NISHIO Breakdown of academic impact, for papers by Sujata K. Dass Breakdown of academic impact, for papers by Jeffrey Sarver Breakdown of academic impact, for papers by Abhay T. Sangamwar Breakdown of academic impact, for papers by Karl Jacob
Rankless by CCL
2026